(Q42710772)

5 November 2017

title

Resveratrol prevents development of eosinophilic rhinosinusitis with nasal polyps in a mouse model (English)

1 reference

5 November 2017

1 reference

1 reference

S-W Kim

1

1 reference

5 November 2017

D W Kim

2

1 reference

5 November 2017

R Khalmuratova

3

1 reference

5 November 2017

J H Kim

4

1 reference

5 November 2017

M H Jung

5

1 reference

5 November 2017

D-Y Chang

6

1 reference

5 November 2017

E-C Shin

7

1 reference

5 November 2017

H-K Lee

8

1 reference

5 November 2017

H-W Shin

9

1 reference

5 November 2017

C-S Rhee

10

1 reference

5 November 2017

S-Y Jeon

11

1 reference

5 November 2017

Y-G Min

12

1 reference

5 November 2017

publication date

10 June 2013

1 reference

5 November 2017

1 reference

5 November 2017

volume

68

1 reference

5 November 2017

issue

7

1 reference

5 November 2017

page(s)

862-869

1 reference

Nasal polyps: pathogenesis and treatment implications

5 November 2017

cites work

1 reference

Pharmacological management of nasal polyposis

21 January 2018

1 reference

The phenomenon of resveratrol: redefining the virtues of promiscuity

21 January 2018

1 reference

Anti‐inflammatory effects of resveratrol: possible role in prevention of age‐related cardiovascular disease

21 January 2018

1 reference

Safety of resveratrol with examples for high purity, trans-resveratrol, resVida(®).

21 January 2018

1 reference

Staphylococcus aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model

21 January 2018

1 reference

Anti-inflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma

21 January 2018

1 reference

Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase

21 January 2018

1 reference

LTC4 synthase. Enzymology, biochemistry, and molecular characterization

21 January 2018

1 reference

Leukotrienes and airway inflammation

21 January 2018

1 reference

Role of 5-lipoxygenase in resveratrol mediated suppression of 7,12-dimethylbenz(α)anthracene-induced mammary carcinogenesis in rats

21 January 2018

1 reference

Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity

21 January 2018

1 reference

Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A₄hydrolase

21 January 2018

1 reference

Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function

21 January 2018

1 reference

trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and degranulation

21 January 2018

1 reference

Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro

21 January 2018

1 reference

21 January 2018

IL-5 and eosinophilia.

1 reference

Resveratrol (trans-3,5,4'-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor

21 January 2018

1 reference

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.

21 January 2018

1 reference

Resveratrol inhibits transforming growth factor-β-induced proliferation and differentiation of ex vivo human lung fibroblasts into myofibroblasts through ERK/Akt inhibition and PTEN restoration.

21 January 2018

1 reference

Resveratrol inhibits paraquat-induced oxidative stress and fibrogenic response by activating the Nrf2 pathway

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ALL.12132

1 reference

release_q6euqzsu2jf4nmek6i6i3xw3fq

5 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/q6euqzsu2jf4nmek6i6i3xw3fq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference